Bayer (BAYN.DE) shares are down around 7% early this week after the company received a Roundup verdict and was ordered to pay a $2.1 billion penalty. The company has already paid out a total of $10 billion to settle disputed claims, and more than 66,000 more cases are still pending.
A jury in Georgia, South Carolina, US, has ordered Monsanto parent company Bayer to pay damages to a man who claims the company’s Roundup weedkiller caused him cancer. “Bayer will likely be able to significantly reduce the punitive damages on appeal, as well as appeal the jury’s findings, although this will take some time,” JP Morgan analysts added.

The company’s shares are once again negating gains on the 200-day EMA (golden line on the chart) and extending a long-term downtrend.
Source: xStation
Stock of the Week: Micron. The Memory Cycle in the Age of Artificial Intelligence
US Open: Micron restores faith in the never-ending AI boom
Record after record: Micron smashes Q4 results, server overload crashes website, stock surges post-market
📊Daily Summary: PCE inflation slowdown brings relief to Wall Street, but oil continues gains despite return of supply